Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs. Tedeholm H, Lycke J, Skoog B, Lisovskaja V, Hillert J, Dahle C, Fagius J, Fredrikson S, Landtblom A-M, Malmeström C, et al. Mult Scler. 2012 Nov 1. PMID: 23124789. Abstract CommentRecommendBookmarkWatch